Atrial fibrillation	AF
Percutaneous coronary intervention	PCI
Coronary artery disease	CAD
Vitamin K antagonists	VKAs
Non–vitamin K antagonist oral anticoagulants	NOACs
Dual antiplatelet therapy	DAPT
Acute coronary syndrome	ACS
Myocardial infarction	MI
Stent thrombosis	ST
Triple antithrombotic therapy	TAT
Oral anticoagulants	OAC
Randomized controlled trials	RCTs
Single antiplatelet therapy	SAPT
International Society on Thrombosis and Hemostasis	ISTH
Thrombolysis in Myocardial Infarction	TIMI
Major adverse cardiovascular events	MACE
Confidence interval	CI
Dual antithrombotic therapy	DAT
Hazard ratio	HR